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Corneal blindness is the fourth leading cause of visual impairment. Of specific
interest is blindness due to a dysfunctional corneal endothelium which can
only be treated by transplanting healthy tissue from a deceased donor.
Unfortunately, corneal supply does not meet the demand with only one donor
for every 70 patients. Therefore, there is a huge interest in tissue engineering
of grafts consisting of an ultra-thin scaffold seeded with cultured endothelial
cells. The present research describes the fabrication of such artificial
Descemet membranes based on the combination of a biodegradable
amorphous polyester (poly (d,l-lactic acid)) and crosslinkable gelatins. Four
different crosslinkable gelatin derivatives are compared in terms of
processing, membrane quality, and function, as well as biological
performance in the presence of corneal endothelial cells. The membranes are
fabricated through multi-step spincoating, including a sacrificial layer to allow
for straightforward membrane detachment after production. As a
consequence, ultrathin (<1 µm), highly transparent (>90%), semi-permeable
membranes could be obtained with high biological potential. The membranes
supported the characteristic morphology and correct phenotype of corneal
endothelial cells while exhibiting similar proliferation rates as the positive
control. As a consequence, the proposed membranes prove to be a promising
synthetic alternative to donor tissue.
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The cornea is the clear membrane that
provides the eye a window to the exterior
world. Several diseases or trauma can lead
to an opaque cornea resulting in impaired
vision and eventually blindness.[1,2] Many
can only be treated with (partial) corneal
transplantation, which is performed around
200 000 per year according to the most re-
cent sources. Of that amount, around 40%
are performed to cure corneal endothelial
blindness.[3,4]
These patients suffer from an oedema-
tous cornea due to a dysfunctional corneal
endothelium, which is a monolayer of
hexagonally shaped cells that covers the
posterior corneal surface.[5] This cell layer is
principally responsible for maintaining the
cornea in a physiological state of deturges-
cence, which is imperative for its trans-
parency. Corneal endothelial cells are in-
capable to undergo in vivo regeneration,
meaning that the absolute number of cells
will only decrease throughout life which can
be further exacerbated by disease or trauma.
When corneal endothelial cell density falls
under a threshold of 500 cells mm−2, corneal edema ensues lead-
ing to opacification and irreversible visual impairment.[6]
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Currently, the standard of care is to surgically strip the dysfunc-
tional cell layer and its underlying Descemet basement mem-
brane from the corneal stroma and replace this with a viable
corneal endothelium of a cadaveric donor cornea, termed en-
dothelial keratoplasty.[7] More specifically, in Descemet stripping
automated endothelial keratoplasty (DSAEK) the graft consists
of endothelial cells, the Descemet membrane and some residual
stroma that is inserted using a specialized cannula after which
it automatically unfolds in the anterior chamber. In Descemet
membrane endothelial keratoplasty (DMEK), there is no residual
stroma, resulting in a thinner graft that spontaneously forms a
roll that is unscrolled with an air bubble by the surgeon.[6] Re-
gardless of good visual outcomes and minimal surgery-related
complications, there is a severe global donor shortage that lim-
its the number of corneal (endothelial) transplantations. A recent
survey estimates that, in general for corneal transplantation, only
one in 70 people requiring a donor cornea can be treated.[8]
This unfortunate situation has incited researchers to develop
a cell therapy, based on the ex vivo expansion of corneal endothe-
lial cells from one donor cornea to provide multiple patients
with an answer to their sight-threatening condition. Recently, Ki-
noshita et al. have treated the very first patients with an injec-
tion of a corneal endothelial cell suspension and reported good
visual recovery up to 2 years later.[9] Nevertheless, currently, the
most investigated strategy is to create composite grafts of cells
seeded onto a scaffold enabling transplantation similar to the cur-
rently applied corneal endothelial grafts. Such cell carriers, how-
ever, must exhibit very specific properties, such as transparency,
glucose permeability, cytocompatibility, and above all, they must
maintain the correct endothelial cell phenotype.[10] To date, at-
tempts have been made to find an ideal corneal endothelial scaf-
fold, which range from biological and biosynthetic to fully syn-
thetic membranes. However, no candidate scaffold has met all
requirements yet, nor has one effectively entered the clinic.[11]
An attractive scaffolding material in this respect is gelatin,
which is obtained via hydrolysis of collagen, the main constituent
of the natural extracellular matrix (ECM), rendering it a promis-
ing material for tissue engineering.[12] Furthermore, it is inex-
pensive, non-immunogenic, considered safe by the Food and
Drug Administration (FDA) and displays the ability to be pro-
cessed in line with a variety of applications.[12,13] Furthermore,
due to the breakdown of the tertiary collagen protein struc-
ture into gelatin, it contains RGD (arginine-glycine-aspartic acid)
motifs that promote cell attachment, rendering it cytocompati-
ble and cell-interactive.[14] Furthermore, gelatin exhibits physi-
cal gelation properties, resulting in the formation of a hydrogel
below its gel temperature (i.e., 30–35 °C).[15] Since this temper-
ature is below the physiological temperature, it is often chemi-
cally modified to introduce chemical crosslinks to stabilize the gel
above this gel temperature.[12,15–17] In the past, gelatin has already
been used for corneal endothelial tissue engineering as a func-
tionalized scaffold to grow cells on or as a bio-adhesive gelatin
disc for transplantation.[18,19]
In this paper, we envisaged a combination of modified gelatin
and a biodegradable polyester (i.e., poly(D,L-lactic acid), PDLLA),
to develop a biocompatible scaffold for corneal endothelial trans-
plantation. On the one hand, modified and crosslinked gelatins
provide an ideal, stabilized ECM mimic to introduce cyto-
compatibility and cell interactivity. On the other hand, an un-
derlying PDLLA polyester base should provide the transplant
with mechanical strength, thereby enabling corneal endothelial
transplantation.
2. Experimental Section
2.1. Reagents and Consumables
Gelatin type A and B, isolated by an acidic and alkaline process
respectively, was kindly offered by Rousselot. Furthermore,
1,4-dithiothreitol (DTT) (≥97%), glucose assay kit, acetic acid
3-(trimethoxysilyl) propyl methacrylate (98%), methacrylic
anhydride (94%), NaOH, tetrahydrofurane (THF), and 5-
norbornene-2-carboxylic acid were bought from Sigma-Aldrich.
The PURASORB PDL 20 (PDLLA) was obtained at Corbion Purac
(DMF-21817). Irgacure 2959 was supplied by BASF. Anhydrous
K2HPO4 and Na2HPO4 were purchased at Fisher Scientific
and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC),
N-hydroxysuccinimide (NHS), and Toluene were acquired from
Acros Organics. Dimethyl sulfoxide (DMSO) was obtained from
Chemlab, deuterium oxide from Euriso-top, and 2-aminoethyl
methacrylate hydrochloride (AEMA.HCl) was purchased from
Polysciences . Finally, dialysis membranes spectra/por (MWCO
12.000–14.000 g mol−1) were obtained from Polylab . All reagents
were used as received unless stated otherwise.
2.2. Preparation of Gelatin B Derivatives
2.2.1. Methacrylation of the Primary Amines in Gelatin B
The methacrylation of gelatin B, with the aim of obtaining gel-
MOD (also known as gel-MA), was performed as described
earlier.[16] Briefly, 100 g gelatin type B (38.5 mmol amines) was
dissolved in 1 L of phosphate buffer (pH 7.8) at 40 °C under
continuous mechanical stirring. Next, either 1 (i.e., 5.736 mL,
38.5 mmol) or 2.5 equiv. (i.e., 14.34 mL, 96.25 mmol) methacrylic
anhydride were added and allowed to react for 1 h to obtain a
high and a low degree of substitution (DS). After 1 h, the reaction
mixture was diluted with 1 L double distilled water (DDW) (𝜌 =
18.2 MΩ cm) followed by dialysis against distilled water (MWCO
12 000−14 000 g mol−1) during 24 h at 40 °C, with the water being
changed five times. The pH of the solution was adjusted to ≈7.4
using a 5 m NaOH solution. Finally, the gel-MOD was isolated
by freezing and lyophilization (Christ freeze-dryer alpha I-5). The
degree of substitution (DS) was determined using 1H-NMR spec-
troscopy using D2O as solvent at elevated temperature (40 °C) as
reported earlier resulting in derivatives with a DS of 63% or 95%,
respectively.[20]
2.2.2. Methacrylation of the Carboxylic Acids Present in Gel-MOD
Gel-MOD-AEMA was prepared following a previously reported
protocol.[21] Fully functionalized gel-MOD (DS 95%) (10 g,
10.980 mmol carboxylic acids) was dissolved in 300 mL of dry
DMSO (obtained via vacuum distillation over CaH2) at 50 °C
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under inert argon atmosphere. After complete dissolution, 1
equiv. of EDC (2.1 g; 10.980 mmol) and 1.5 equiv. NHS (1.895 g;
16.48 mmol) were added together with 50 mL dry DMSO. Af-
ter 30 min, 1.5 equiv. 2-aminoethyl methacrylate hydrochloride
(AEMA.HCl) (2.729 g, 16.47 mmol) was added together with
50 mL of dry DMSO after which the solution was shielded from
light and stirred overnight at 50 °C. DMSO was removed by dial-
ysis (MWCO 12 000–14 000 g mol−1) at 40 °C during 24 h in
distilled water followed by freezing and lyophilization. 1H-NMR
spectroscopy in deuterium oxide was performed at 40 °C to de-
termine the degree of substitution according to a previously re-
ported protocol.[21]
2.2.3. Introduction of Norbornene Functionalities onto Gelatin
Gelatin-norbornene (gel-NB) was synthesized following a previ-
ously reported protocol.[21] In brief, the carboxylic acid function-
alities in 5-norbornene-2-carboxylic acid were converted into an
activated succinimidyl ester via reaction with EDC and NHS dur-
ing 25 h, using a 1.25 times excess of 5-norbornene-2-carboxylic
acid (relative to the amount of EDC added) to prevent the pres-
ence of unreacted EDC molecules which can on the one hand
result in the formation of zero-length crosslinks between the pri-
mary amines and the carboxylic acids present in gelatin.[22] On
the other hand, it is of predominant importance that all the EDC
is reacted primary to the addition to the gelatin, as the combi-
nation of a carbodiimide and an acid catalyst (5-norbornene-2-
carboxylic acid) in DMSO could result in oxidation of the alcohols
present in gelatin to their respective aldehyde or ketone follow-
ing a Pfitzner–Mofatt-oxidation.[23] These aldehydes could also
result in crosslinking of the gelatin via reaction with the primary
amines of gelatin resulting in Schiff’s base formation.[12] To this
end, EDC and NHS were dissolved in a respective 1:1.5 ratio in
dry DMSO under argon atmosphere. In a next step, the temper-
ature was raised to 50 °C and gelatin type B was added to the
reaction mixture resulting in 0.75 equiv. of norbornene succin-
imidyl ester relative to the primary amines present in gelatin
(0.385 mmol g−1) and allowed to react for another 20 h. Next, the
mixture was precipitated in a tenfold excess of acetone, filtered
on filter paper (VWR, pore size 12–15 µm) using a Büchner filter
to remove the formed ureum side products and DMSO, followed
by dissolving in DDW and dialysis for 24 h against distilled water
(MWCO 12–14 kDa). After dialysis, the pH of the mixture was
adjusted to ≈7.4 using a 5 m NaOH solution. Finally, the pure
product was isolated by freezing and lyophilization. The DS was
assessed using 1H-NMR spectroscopy in D2O at 40 °C as previ-
ously reported.[21] The derivative exhibited a DS of 63%.
2.3. Polymer Characterization
2.3.1. Nuclear Magnetic Resonance Spectroscopy
The 1H-NMR spectra of the gelatin derivatives were recorded at
40 °C using a 500 MHz Bruker Avance II Ascend spectrome-
ter. All other 1H-NMR spectra were recorded using a 400 MHz
Bruker Avance II Ultrashield spectrometer at room temperature.
Analysis of the obtained spectra was performed using MestReN-
ova software.
2.3.2. Photo-Rheology
Photo-rheological measurements were performed on an Anton–
Paar Physica MCR 301 rheometer using a plate-plate geome-
try (upper plate diameter: 25 mm). All measurements were per-
formed at 37 °C at an oscillation frequency of 1 Hz with a strain
of 0.1% (selected based on the linear viscoelastic area as previ-
ously reported) and a gap setting of 0.35 mm.[16] Samples were
trimmed, sealed with vacuum grease to prevent drying (Bayer sil-
icone, mittelviskös, VWR) and irradiated through a quartz glass
bottom plate using UV-A light at 365 nm and an intensity of
500 mW cm−² (EXFO Novacure 2000 UV light source). Samples
were irradiated with UV light for 10 min and were measured dur-
ing this treatment and 2 min before and after. All applied samples
were crosslinked at a 10 w/v% gelatin concentration in the pres-
ence of 2 mol% Irgacure 2959 as photoinitiator, relative to the
number of crosslinkable functionalities. The norbornene deriva-
tive solutions also contained 0.5 equiv. DTT as a crosslinker cor-
responding to an equimolar thiol-ene ratio, allowing for efficient
crosslinking.
2.3.3. Size Exclusion Chromatography
Size exclusion chromatography was performed on the PDLLA
polyesters to determine the number average molecular weight
(Mn), weight average molecular weight (Mw), and polydispersity
index. The measurements were performed on a Waters Alliance
2695 set-up (Zellik, Belgium) coupled to an Agilent (Diegem, Bel-
gium) guard column (PLGel 5 µm) and a mixed-D LS polystyrene-
divinylbenzene (300 × 7.5 × 5 µm) column from Polymer Labo-
ratories (Middelburg, The Netherlands). Detection was based on
a Waters refractive index detector 2414. The molecular weights
were determined from the obtained retention times via an ex-
ternal calibration curve using polystyrene standards (1.2–177 kg
mol−1). As eluent HPLC grade chloroform at a flow rate of 1 mL
min−1 was applied.
Samples were prepared by dissolving 10 mg of polymer in
2 mL HPLC grade chloroform. The resulting solutions were
passed through a 0.45 µm syringe filter, transferred to a mass
vial, and subsequently analyzed. Furthermore, a correction factor
of 0.58 was applied to the results to compensate for the difference
in hydrodynamic volume between the polystyrene standards and
the PDLLA.[24]
2.4. Membrane Production
Membranes were produced by a multistep spin coating process
in the following order: i) gelatin A, ii) PDLLA, and iii) cross-
linkable gelatin B derivatives, with the specific parameters men-
tioned in Table 1. The purasorb PDL 20 are PDLLA polymers
regulated by the FDA and covered with a Device Master file
(MAF 1961) and drug master file (DMF 31 084).[25,26] After the
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Table 1. Overview of the applied spincoating parameters during the membrane fabrication process.








1 Gelatin A 10 w/v% (in DDW) 750 RPM s−2
(2000 RPM for 60 s)
/ / 60 µL 250 µL
2 PDLLA 4 w/w% (in THF) 1000 RPM s−2
(3000 RPM for 60 s)
/ /
3 Gelatin B gel-MOD 10 w/v% (in PBS) 750 RPM s−2




Gel-MOD-AEMA 10 w/v% (in PBS) /
Gel-NB 10 w/v% (in PBS) DTT (1 to 1 thiol/
ene ratio)
PDLLA layer was deposited, the samples were subjected to a 0.8
mbar Argon plasma treatment for 30 s with a Diener electronic
plasma treatment device to enable a better compatibility and co-
valent attachment of the gelatin derivatives to the PDLLA after
crosslinking.[27,28] Finally, crosslinking of the gelatin B deriva-
tives was performed by hydrating the coated gelatin layer with
60 or 250 µL of DDW (for samples with a diameter of 12 and
25 mm respectively) and irradiating the samples for 10 min from
top and bottom with UV-A light at a wavelength of 365 nm with
an intensity of 4 mW cm−2 using a high performance ultraviolet
transilluminator (ultra violet products).
2.5. Membrane Characterization
X-ray photoelectron spectroscopy (XPS) measurements were per-
formed on four random locations of the measured samples in
duplo for elemental analysis of the spin coated layers. An ESCA
S-probe VG monochromatic spectrometer with an Al K𝛼 X-ray
source (1486 eV) was used to measure a spot size of 250 µm
by 1000 µm, which was analyzed using the Casa XPS software
package.
Static contact angles of the produced membranes were deter-
mined, hereby measurements were conducted on membranes
attached to methacrylated glass slides without the presence of a
sacrificial gelatin layer since no membrane detachment was de-
sired. Measurements were conducted using an OCA 20 device
using the software provided by the supplier (i.e., SCA 20, version
2.1.5 build 16). A 1 µL droplet of DDW was used to determine
the contact angles. The contact angle for each sample was de-
termined as the average during the first 30 s. All measurements
were performed in triplicate.
Transparency of the membranes coated on glass-plates was
measured using a custom made set up consisting of a broadband
halogen light source (Avantes Avalight–Hal) which was guided
toward the sample holder using an optical fiber. The transmitted
light was transferred to a broadband spectrum analyzer (Avantes
Avaspec—2048). In this way transmission at all wavelengths was
measured simultaneously after performing a baseline correction.
Furthermore, during the measurement the sample holder was
covered with a black case to remove influence of stray light. Trans-
mission of all coated glass slides was compared relative to a glass
slide with a gelatin A coating. For the hydrated samples, a droplet
of deionized water (300 µL) was placed on each sample, and they
were allowed to reach equilibrium swelling during 90 min prior
to the measurement.
Finally, the thickness of the membranes was determined with
the use of a BRUKER Contour GT-I white light interferomet-
ric 3D surface metrology optical microscope. Samples were
scratched with metal forceps to expose the multiple layers. The
thickness was then measured from the glass to the top of the
coating using depth profilometry. (see Figure S1, Supporting
Information).
Mechanical analysis was performed on PDLLA basement
membranes. To this end, large samples (d = 25 mm) were de-
tached from the glass slide by dissolving the sacrificial gelatin
layer. Next, they were placed in between two pieces of paper and
cut in ribbons of ≈7–8 mm wide. Next, these ribbons were placed
in a tensile testing device followed by removal of the paper (Lloyd
TA500 Texture Analyser, equipped with a 10 N load cell) and the
exact width and gauge length of the sample were measured us-
ing digital calipers. The thickness of the samples was selected as
the average from the optical profilometry measurements (see Fig-
ure 4E). The samples were stretched at a speed of 5 mm min−1
while monitoring the load (in N). From this data, stress-strain
plots were generated where the strain (%) is obtained by divid-
ing the elongation by the gauge length, whereas the stress (MPa)
is obtained by dividing the measured load by the surface area of
the sample (width × thickness). The Young’s modulus was calcu-
lated from the slope of the linear part of the stress-strain curves.
All experiments were performed in triplicate.
Glucose diffusion was evaluated by placing a membrane in a
side-by-side diffusion set up. To this end, a 10 w/v% glucose solu-
tion in double distilled water was prepared with 0.5 w/v% sodium
azide added to prevent growth of micro-organisms. The setup is
built up out of two diffusion cells, each diffusion cell is supplied
with a stirring bar and kept at a constant 37 °C. The produced
membranes were clamped between the diffusion cells. One of
the two diffusion cells is filled with 2.5 mL of the previously pre-
pared glucose solution, termed the donor cell. The other diffu-
sion cell is filled with 2.5 mL of double distilled water, which is
the acceptor cell. The acceptor cell is periodically emptied inside
a mass tube and then refilled with 2.5 mL double distilled wa-
ter. The collected fractions of the acceptor cell are then diluted
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100 times and analyzed using a glucose oxidase assay. The appar-









is the change in concentration over time as deter-
mined by the linear regression of the measurements at different
time points (mol s−1).
A is the exposed surface of the membrane (cm²) (i.e., 0.79 cm²).
C0 is the initial glucose concentration (mol cm
−³) (i.e., 0.55 ×
10−3 mol cm−³).
2.6. Biological Assays
Glass coverslips coated with the gelatin B derivatives were used in
order to test the interaction between gelatin and endothelial cells
without the sacrificial gelatin A layer or the PDLLA. The glass
coverslips were first methacrylated to ensure covalent attachment
between the gelatin derivatives and the glass coverslips.
To this end, they were cleaned with DDW, acetone, and sub-
jected to a 3-min argon plasma treatment. Following this, they
were incubated in a mixture containing 50 mL DDW, 48 mL
ethanol, 0.3 mL acetic acid, and 2 mL 3-(trimethoxysilyl) propyl
methacrylate for 30 min followed by thorough rinsing with DDW.
In brief, the spincoated samples on glass coverslips (diameter
12 mm) were secured into a 24 well tissue culture plate using the
cellcrown insert (Scaffdex, Tampere, Finland).
To sterilize the samples, they were incubated in a range from
30–70% ethanol solution with a 10% increment every 30 min.
They were stored overnight in a 70% solution, and irradiated with
UV-C for 30 min. Next, they were rinsed with sterile PBS (3X) and
exposed to UV-C irradiation for another 30 min prior to use.
2.6.1. Cell Culture
B4G12 immortalized corneal endothelial cells (DSMZ, Braun-
schweig, Germany) were cultured according to the manufac-
turer’s instructions with minor modifications. In brief, the cells
were grown on tissue culture treated plastic ware, coated with
an FNC coating mix (Athena Enzyme systems, Baltimore, USA).
The growth medium consisted of human endothelial serum free
medium (Life Technologies) supplemented with 10 ng mL−1 ba-
sic fibroblast growth factor (Life Technologies) without antibi-
otics. B4G12 cells were detached using 0.05% Trypsin-EDTA (Life
Technologies) and subcultured or seeded according to the down-
stream assay.
2.6.2. Immunocytochemistry
Corneal endothelial cells were cultured on glass coverslips coated
with gel-MOD-AEMA, gel-MOD DS63, gel-MOD DS95, gel-NB
DS63. After 7 days in culture, the samples were fixated in ice
cold paraformaldehyde 4% for 30 min, rinsed three times in PBS
1X (Life Technologies) and stained within 1 week. The samples
were permeabilized with PBS1X containing 1% Triton X-100 for
30 min and incubated overnight with a primary antibody raised
against ZO-1 (1:200; Thermo Fisher Scientific, Massachusetts,
USA) or Na+/K+ ATPase (1:40; Santa Cruz Biotechnology, Texas,
USA) for phenotyping. The secondary antibody (goat anti-mouse
FITC 1:500; Jackson Immunoresearch, West Grove, USA) was
incubated for 2 h at room temperature in the dark, followed by
a nuclear stain with 100 µg mL−1 4′,6-diamidino-2-phenylindole
(DAPI) (Sigma, St. Louis, USA) and mounted using Citifluor to
reduce fading (Citifluor, Hatfield, USA). Images were captured
using an UltraView VOX laser spinning disk confocal micro-
scope (Perkin Elmer, Massachusetts, USA) at 20× magnification
and processed using ImageJ.
For the adhesion assay, samples seeded with 25 000 cells for 24
h were subjected to a similar protocol with primary anti-vinculin
antibodies (1:200, Abcam, Cambridge, United Kingdom) and sec-
ondary goat anti-mouse PE conjugated antibodies. Images were
processed according to a previous published protocol.[10] Both
primary and secondary antibodies were diluted in 0.01 m PBS
containing 0.5% Thimerosal, 0.1% NaN3, 10% normal horse
serum, and 0.3% bovine serum albumin.
2.6.3. Proliferation Assay
A proliferation assay was performed in the Incucyte (Sartorius,
Göttingen, Germany), a high-throughput live-cell imaging sys-
tem. B4G12 cells were seeded with a density of 30 000 cells per
well and incubated for 4 h (37 °C, 5% CO2) until adherent. Next,
the nuclei were counterstained with NucLight Rapid Red Reagent
1:2000 (Sartorius, Göttingen, Germany) and imaged every 2 h
(see Video S1, Supporting Information). Using the built-in soft-
ware, custom masking algorithms were generated to quantify cel-
lular growth expressed as #nuclei mm−2 as a function of time.
Growth curves were fitted using Graphpad Prism 8.0 using an
exponential growth fitting curve model and population doubling
times (PDT) were extracted. PDT were then statistically com-
pared to each other using a non-parametric Kruskal–Wallis test
where p < 0.05 was deemed significant.
2.6.4. Primary Corneal Endothelial Cell Culture
Primary corneal endothelial cells were isolated and cultivated ac-
cording to previous reports using a peel-and-digest method.[10,32]
The donor corneas used for this research were excluded from
transplantation and made available for research. Ethical approval
was granted by the local ethical committee (EC14/30/319). First,
the endothelium and Descemet membrane were mechanically
dissected from the posterior cornea using micro-forceps and
an operating microscope. Second, the harvest tissue was fur-
ther digested in a 1 mg mL−1 collagenase 1A (Sigma Aldrich,
St. Louis, USA) for 2 h at 37 °C and 5% CO2. Dislodged cells
were further digested using trypLE Express Enzyme (Thermo
Fisher Scientific, Massachusetts, USA) for 5 min at 37 °C. Fi-
nally, cells were pelleted at 72 × g for 5 min and seeded in an FNC
coated 24 well plate. Two donor corneas of the same donor were
Adv. Healthcare Mater. 2020, 9, 2000760 2000760 (5 of 16) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedsciencenews.com www.advhealthmat.de
pooled and cells were cultivated for 7 days before performing im-
munocytochemistry for ZO-1 and Na+/K+ ATPase as described
earlier.
2.7. Statistics
Statistical significance was analyzed using GraphPad Instat using
a one-way analysis of variance (ANOVA) with bonferroni post-test
in case of a normal distribution and adequate sample size. Non-
parametric Kruskal-Wallis was applied in case of a lower sample.
Statistical significance was defined as *** p < 0.001, ** p < 0.01,
* p < 0.05.
3. Results and Discussion
3.1. Material Development and Characterization
In order to obtain a stable gelatin coating at 37 °C, the mate-
rial needs to be chemically crosslinked to circumvent the phys-
ical dissociation behavior at 30 °C of unmodified gelatins.[15]
Therefore, the present work explores the use of different chemi-
cally modified photo-crosslinkable gelatins including gel-MOD,
gel-MOD-AEMA, and gel-NB.[12,15,16] In this respect, gel-MOD
and gel-MOD-AEMA are crosslinked following a free radical
chain growth polymerization mechanism, whereas gel-NB is
crosslinked using a thiol-ene step growth polymerization mecha-
nism using DTT as thiolated crosslinker. Additionally, derivatives
with a different number of crosslinkable groups were compared.
The first and most common derivative, gel-MOD, was used with
two different degrees of amine substitution, namely 63% and
95% (corresponding to 0.243 and 0.367 mmol g−1 gelatin respec-
tively). These derivatives were obtained via the reaction of the pri-
mary amines present in the (hydroxy)lysine and ornithine amino
acids with 1 or 2.5 equiv. of methacrylic anhydride respectively
(Figure 1; top panel).[16]
Apart from gel-MOD, gel-MOD-AEMA was also assessed,
which is another derivative containing more crosslinkable
functionalities.[15] This derivative is obtained starting from gel-
MOD with a high degree of substitution (i.e., DS 95) via sub-
sequent reaction of the carboxylic acids present in the side
chains of the glutamic acid and aspartic acid amino acids with 2-
aminoethyl methacrylate hydrochloride (AEMA) using carbodi-
imide coupling chemistry (EDC/NHS). As a result, a DS for
the carboxylic acids of 55% was obtained, corresponding to
0.6039 mmol methacrylates per g gel-MOD-AEMA. When com-
bining the latter value with the 0.367 mmol methacrylamides per
g resulting from the amine substitution, a total of 0.97 mmol
crosslinkable groups per g gel-MOD-AEMA was obtained (see
Figure 1, middle panel).[15]
A third crosslinkable gelatin derivative (gel-NB) applies thiol-
ene photo-click chemistry to generate a crosslinked network. For
this derivative, the primary amines of gelatin were functionalized
with 5-norbornene-2-succinimidyl ester, yielding gel-NB with a
DS of 63%, corresponding to 0.243 mmol g−1 gel-NB (Figure 1,
bottom panel).[21]
To compare the different reactivities of the applied derivatives,
photo-rheological measurements were performed on 10 w/v%
solutions in the presence of 2 mol% (in respect to the amount
of incorporated crosslinkable functionalities) Irgacure 2959 as
photoinitiator, and 0.5 equiv. of DTT (i.e a 1:1 thiol:ene ratio)
for the norbornene derivative. Irgacure 2959 was selected as pho-
toinitiator, due to its known biocompatible behavior.[31] The assay
provides insight in the reactivity of the materials as well as the
mechanical properties of the gelatin coatings after crosslinking.
In accordance to previous research, the material with the high-
est density of crosslinkable functionalities (gel-MOD-AEMA) re-
sulted in the highest stiffness as reflected by the storage modulus
(G′) after 10 min of crosslinking.[15] This derivative reached a stor-
age modulus of around 15 kPa whereas gel-MOD DS95 reached
a storage modulus of around 6 kPa. The gel-MOD DS63 and
gel-NB DS63 derivatives yielded storage moduli around 4.5 kPa
(Figure 2; right panel). When Palchesko et al. investigated the
influence of mechanical properties on the expansion behavior
of bovine corneal endothelial cells, they observed the optimal
Figure 1. Applied gelatin modification strategies via the introduction of methacrylamides (red) yielding gel-MOD; the subsequent introduction of
methacrylates into gel-MOD yielding gel-MOD-AEMA (green), and the introduction of norbornene functionalities (blue) yielding gel-NB.
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Figure 2. Photo-rheological monitoring of crosslinking kinetics and resulting mechanical properties at 37 °C with the evolution of the storage moduli
(G′) depicted as solid lines, whereas the loss modulus (G′′) is depicted using dashed lines. (Left panel); Average gel-points (in seconds) after switching
on the UV light for the different crosslinking systems as a measure of crosslinking reactivity (n = 3) (Right panel). All differences were significant with
p < 0.001 except for the ones indicated in the picture with * (p < 0.05) or ns (not significant).
mechanical properties being around a Young’s modulus (E′) of
50 kPa, which resembles the microscopic Young’s modulus of
the Descemet membrane (i.e., as perceived by the cells).[33,34] To
put this in perspective, we made an estimation for the Young’s
modulus (E′) following Equation (2).[35]
E′ = 2G′(1 + 𝜇) (2)
Here, 𝜇 is the Poisson number which equals 0.5 for ideal rub-
bery materials, which is a good approximation for hydrogels.[35,36]
As a consequence, the gel-MOD-AEMA derivative reaches a
Young’s modulus of around 45 kPa, while the high DS gel-MOD
reach Young’s moduli around 18 kPa and the low DS gel-MOD
and the gel-NB derivatives around 13.5 kPa. As a consequence,
the gel-MOD-AEMA should provide the closest match to the re-
ported optimal Young’s Modulus of 50 kPa.[33,34]
We compared the gel points of the different materials as an
indication of reactivity thereby providing information about the
minimally required irradiation time. Here, the drastic increase in
reactivity for norbornene derivatives over the more conventional
systems is apparent (Figure 2; right panel). The norbornene
derivative has a gel point in the range of a few seconds (i.e.,
2–3) versus > 50 s for the gel-MOD derivatives, with the gel-
MOD-AEMA derivative being intermediate, at ≈15 s (see Fig-
ure 2; right panel). The faster crosslinking kinetics are the con-
sequence of different aspects. First, the norbornene systems are
crosslinked using a thiolated crosslinker (DTT) following thiol-
ene photo-click chemistry which is not prone to oxygen inhibition
and therefore not associated with a lag time after switching on the
UV light during which residual oxygen would need to be con-
sumed prior to initiation.[37,38] Second, especially thiol-ene reac-
tions exploiting norbornene functionalities as “-ene” moiety are
characterized by a very high reactivity due to the ring strain relief
and the rapid subsequent hydrogen-abstraction of a thiol hydro-
gen by the carbon-centered radical.[39] Additionally, the increased
reactivity of gel-MOD-AEMA over conventional gel-MOD is the
consequence of two other factors. First, methacrylates exhibit a
higher reactivity in comparison to the methacrylamides present
in gel-MOD. Second, the photoinitiator is added in a 2 mol% ratio
relative to the number of crosslinkable groups present. Since gel-
MOD-AEMA has roughly three times more crosslinkable groups,
likewise three times more radicals will be formed at the same
time in the gel-MOD-AEMA solution upon irradiation resulting
in higher degrees of initiation culminating in a faster increase in
mechanical properties. However, this also increases the probabil-
ity of termination which can hamper the reactivity. On the other
hand, due to the presence of more crosslinkable functionalities,
the probability of termination will again be lower as the formed
radicals will have a higher chance to encounter unpolymerized
methacryloyl functionalities rather than recombining with an-
other radical.
Furthermore, although the introduction of crosslinks in the
gelatin derivatives result in stability at physiological conditions,
the reported gelatin derivatives still exhibit their favorable enzy-
matic biodegradability as previously reported for gel-MOD, gel-
MOD-AEMA, and gel-NB.[15,40]
3.2. Membrane Production
To obtain ultrathin membranes (i.e., the natural Descemet mem-
brane exhibits thicknesses around 10–12 µm[30]), a multi-step
spin coating approach was applied. First, a layer of unmodified
gelatin A was applied on a supporting glass substrate, as sacri-
ficial layer to enable dissolution in a final step after incubation
in water at 40 °C to enable membrane harvesting (see Video S3,
Supporting Information). Next, a polyester base membrane was
applied through spin coating, starting from a solution of PDLLA
in THF. To this end an amorphous poly(D,L-lactide) of 150 kg
mol−1 and a polydispersity of 1.13 was chosen for several rea-
sons. First of all, PDLLA is an FDA-approved generally recog-
nized as safe polymer for use in the human body with many
applications in drug products and multiple FDA medical device
approvals including the use as dermal fillers or bioresorbable
vascular stents.[41–43] Second, PDLLA was chosen over the more
conventional PLLA as PDLLA is an amorphous material which
results in a high transparency.[44] Finally, PDLLA is a biodegrad-
able material resulting in non-toxic lactic acid based degradation
products as previously reported.[45] This is a specific benefit to-
ward corneal endothelial repair as in vivo 85% of the glucose
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Figure 3. A) The principle of spin coating. B) The final composition of the obtained membranes. C) Scheme of the multistep spin coating approach to
produce the membranes.
nutrients which enter the cornea is metabolized to lactic acid,
which diffuses back through the corneal endothelium. As a con-
sequence, the tissue is characterized by relatively high lactic acid
concentrations (i.e., 13 mm in the cornea and 7 mm in the an-
terior chamber).[46] Therefore, it is anticipated that PDLLA is an
ideal scaffolding material, as the degradation products will not
induce any inflammation and the lactate is even considered as
a contributing anion flux to maintain corneal transparency.[46]
To allow covalent adhesion between the polyester and the subse-
quent crosslinkable gelatin layer, the surface was activated using
a plasma treatment.[28] Finally, the crosslinkable gelatin solution
was applied starting from a solution containing 2 mol% Irgacure
2959, and an equimolar amount of thiols (DTT) with respect to
the NB functionalities for the gel-NB derivative.[21] Gelatin was
chosen as an extra cellular matrix mimic due to the structural
similarities with collagen, the main component of the natural
Descemet membrane.[22,47] Furthermore, the material is known
to be biodegradable resulting in the formation of peptides in
vivo, similarly to collagen breakdown in the human body.[12,15,48]
Crosslinking and covalent attachment of this gelatin layer oc-
curred by UV irradiation after prewetting of the surface with dou-
ble distilled water.[27] Finally, the membranes were detached by
immersion in water above the gel temperature of gelatin (i.e.,
± 30 °C) (Figure 3C and Video S2, Supporting Information).[15] In
respect of membrane fabrication, it should be noted that the gel-
MOD-AEMA derivative exhibits a benefit over the other reported
derivatives, as the high degree of modification hampers triple he-
lix formation resulting in solubility at room temperature.[15,22,49]
As a consequence, material manipulation during spin coat-
ing becomes more straightforward (i.e., a more homoge-
neous deposition) as there are no issues with premature gel
formation.
3.3. Membrane Characterization
XPS elemental surface characterization was performed after
each of the aforementioned steps in the multi-step spin coating
process to validate the successful application of the respective lay-
ers. The results show that the elemental composition of the sur-
face differed after each step. There was an anticipated high sili-
cium level (i.e., ±20%) from the glass substrate and nitrogen sig-
nal in the (modified) gelatin layers (i.e.,±4% to±16%)(Figure 4A)
as a consequence of the peptide backbone and the nitrogen atoms
present in the side chains of the (hydroxy)lysine, ornithine, his-
tidine, proline, and arginine amino acids present in gelatin.
Additionally, the N/C ratio diminished with increasing degree
of substitution for the gelatin derivatives since more carbons
are attached per amine (i.e., from ±0.18 to ±0.05). Especially
for gel-MOD-AEMA, this ratio drastically decreased since the
introduced AEMA functionalities have a very high C/N ratio
(i.e., 6/1). Furthermore, when looking at the O/C ratio of the
PDLLA membrane, this corresponds to 0.67 thereby proving
that indeed the surface was covered with PDLLA since every
repeating unit in the polymer chain contains three carbon atoms
and two oxygen atoms.
Further proof of a successful coating process could be found
by measuring the static contact angle of water on the differ-
ent substrates (Figure 4B). After initial coating of the glass with
PDLLA, the contact angle increased (i.e., from 69° to 81°) due to
the relatively hydrophobic nature of PDLLA. After plasma treat-
ment, reactive oxygen containing functional groups are intro-
duced at the surface, which leads to an increased hydrophilic-
ity as evidenced by a decreased contact angle (i.e., 55°).[27,51]
Subsequent coating with the gelatin derivatives reduces this hy-
drophilicity. However, when comparing the non-plasma treated
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Figure 4. A) X-ray photoelectron spectroscopy elemental analysis of the top layer of the membrane during stepwise membrane production. B) Static
contact angle measurements indicating hydrophilicity on the different membranes. C) Glucose permeability of the different membranes relative to the
natural Descemet membrane.[50] D) Transparency of the different membranes throughout the visual spectrum both in the dry (solid lines) and in the
hydrated state (dashed lines) (n = 4). E) Membrane thickness measurements, as determined using optical profilometry. (All statistical differences are
denoted with * for p < 0.05, ** for p < 0.01 and *** for p < 0.001 with the exception of panel (A) where all differences are p < 0.001 unless denoted
otherwise (with “ns” representing no statistical significance).
PDLLA with the gelatin coatings, a significant difference can
be observed, thereby again confirming successful membrane
functionalization. Although some differences between the dif-
ferent gelatin coatings appear present, these are non-significant
with the exception between gel-MOD DS 63 and gel-MOD-
AEMA where gel-MOD-AEMA is significantly more hydrophilic
(p < 0.05).
3.4. Membrane Function
One of the predominant requirements of an artificial Descemet
membrane is that it should be sufficiently transparent in the
visual range (i.e., ≥90% for the natural Descemet membrane[10]),
not to impair the vision of the patient after transplantation.[11]
When assessing the transparency of the produced membranes
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Figure 5. Stress–strain plot of the PDLLA membranes obtained via tensile tests (left panel). Zoom of the linear region and calculated Young’s moduli
as determined by the slope (right panel).
qualitatively, it seems that throughout the different production
steps, the membranes exhibited comparable transparency in
reference to the glass slide on which they were coated, since
the underlying pattern can clearly be distinguished (Figure 6).
Additionally, after isolation from the supporting glass slide
by dissolution of the sacrificial gelatin layer (Figure 6H), the
membranes exhibited sufficient mechanical integrity to allow
for surgical manipulation (see Videos S2 and S3, Supporting
Information). It should be noted that in contrast to natural donor
endothelium, the currently reported membranes did not exhibit
the same self-scrolling behavior of a DMEK graft. However, it
is anticipated, that the scaffold could be introduced by using a
suitable surgical tool to introduce it into a cannula similar to a
DSAEK procedure.[19]
As a proof of concept experiment toward surgical manipula-
tion, the membranes could be mounted into cell crowns without
rupturing (Figure 6K,L). To quantify the mechanical integrity of
the developed membranes, they were subjected to tensile tests to
determine the Young’s moduli. In this respect, only the mechan-
ical properties of the base PDLLA membranes were measured in
the absence of the gelatin coating. This was done deliberately, as
the gelatin coating, a soft hydrogel with a Young’s modulus in the
range of a few kPa (vide supra) which will have a negligible effect
in comparison to PDLLA which is a robust polyester. Indeed, the
tensile tests indicated that the PDLLA membranes are charac-
terized by a Young’s modulus of 4.95 ± 0.81 MPa, which is two
orders of magnitude higher than the calculated Young’s moduli
for the gelatin hydrogels (Figure 5). These mechanical properties
further demonstrate the suitability of the developed membranes
as corneal endothelial scaffolds, as literature states that the
natural Descemet membrane is characterized by a comparable
macroscopic Young’s modulus (i.e., 2.5–5 MPa).[50,52] Since
similar mechanical properties are obtained in comparison to the
natural Descemet membrane, the membranes should also allow
surgical manipulation using conventional surgical techniques
applied for the transplantation of natural Descemet membranes.
Additionally, also after membrane isolation, still sufficient
transparency was observed (i.e., PDLLA + gel-MOD-AEMA in
Figure 6I,J). Although, it should be noted that transparency was
somewhat compromised in the dry state (Figure 6I) due to wrin-
kling of the membrane. However, after rehydration, (Figure 6J)
the underlying pattern becomes very clear again, indicating
sufficient transparency. Quantitative spectrophotometric mea-
surements indicated that all membranes exhibited over 90%
transparency in the visual spectrum in the dry state with gel-
MOD-AEMA being the least transparent (i.e., 90–94%) while still
exhibiting a comparable transparency to the natural Descemet
membrane.[10] (Figure 6D) In addition, the transparency of the
membranes was also assessed on hydrated samples to provide
a better mimic of the natural tissue. being more representative
for in vivo conditions. After hydration, the transparency of the
gelatin-coated materials increased to >97% for all membranes
with no significant differences in transparency whereas the un-
coated PDLLA membrane exhibited transparencies around 100%
throughout the spectrum however also not significantly higher
in comparison to the gelatin coated membranes. Since the
natural Descemet membrane is characterized by 90% trans-
parency in the visual spectrum, these membranes proof to
be suitable as a natural Descemet membrane substitute with
respect to optical characteristics.[10]
Additionally, the thickness of all membranes (i.e., <1 µm) was
below the thickness of the natural Descemet membrane (i.e., 10–
12 µm) thereby qualifying as a proper surrogate Descemet mem-
brane in terms of dimensions (Figure 4E). Other gelatin-based
hydrogels that have been reported earlier for corneal endothelial
tissue engineering are either crosslinked with toxic reagents[53]
or are thicker.[18,19,54] Thick constructs would eventually lead to
loss of visual acuity in patients.[10,30,55] Furthermore, experiments
indicate that one way to tune the thickness of the membranes
without affecting the transparency is to apply multiple coatings
on top of each other rather than changing the concentration of
the polymer in the spin coating solution (see Figure S2, Support-
ing Information).
The most important function of corneal endothelial cells is to
maintain the stroma in a state of deturgescence using a pump-
and-leak mechanism, whilst providing the cornea with nutrients
(mostly glucose), from the anterior chamber by passive leakage.[6]
As a consequence, the synthetic membranes need to exhibit suf-
ficient diffusion capacities, which was assessed using a glucose
diffusion assay in a side- by-side diffusion cell set-up (Figure 4C).
The results showed that the PDLLA membranes enable efficient
trans-membrane diffusion of glucose (i.e., permeability coeffi-
cient of Papp = 1.52 × 10−2 ± 6.19 × 10−3 cm s−1), which can
be considered the limiting layer due to the hydrophobicity of the
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Figure 6. Photographs of the produced membranes: after spin coating on glass slides demonstrating the transparency qualitatively. A) Blank glass;
B) glass + gelatin A; C) glass + gelatin A + PDLLA; D) glass + gelatin A + PDLLA + gel-MOD DS 63; E) glass + gelatin A + PDLLA + gel-MOD DS 95;
F) glass + gelatin A + PDLLA + gel-MOD-AEMA; G) glass + gelatin A + PDLLA + gel-NB DS 63. H) The isolation of the membrane after dissolving the
sacrificial gelatin A. After isolation from the glass slide: I) in the dry state and J) after hydration. K,L) mounted in a CellCrown in a respective dry and
hydrated state.
PDLLA. Furthermore, introducing a crosslinked gelatin layer did
not lead to any significant differences in permeability between
the membranes thereby confirming that the PDLLA layer is in-
deed the limiting factor (Table 2 and Figure 4C). When compar-
ing these values to literature, the diffusion still surpasses that of
natural Descemet membranes (i.e., 1.2 × 10−5 cm s−1).[29] The
obtained permeability coefficients are several orders of magni-
tude higher than the ones recorded for the natural Descemet
membrane (Table 2). We anticipate that higher diffusion values
are more desirable than lower diffusion values as this does not
preclude the pumping function of the cells, while allowing suf-
ficient transport of nutrients toward the stroma. Furthermore,
when combining the permeability coefficients with the measured
membrane thicknesses, the diffusion coefficients (D) can be cal-
culated based on Equation (3).[54]
D = Papp × T (3)
With T being the membrane thickness (cm);
The obtained diffusion coefficients are represented in Table 2.
When comparing these values to previously reported values from
literature (i.e., D = 2.55 × 10−7 cm² s−1 for gelatin and atelocolla-
gen membranes) it can be concluded that a similar order of mag-
nitude was obtained.[18]
3.5. In Vitro Biological Assays
3.5.1. Corneal Endothelial Cell Culture
B4G12 immortalized corneal endothelial cells were seeded at a
density of 15 000 cells cm−2. Cell attachment to the membranes
was observed 4 h after seeding and cells grew to confluency after
1 week of culture on a 12 mm diameter membrane. In every con-
dition, the typical hexagonal morphology of corneal endothelial
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Table 2. Comparison of the permeability coefficient (Papp), membrane thickness, and calculated diffusion coefficients (D) from these values compared
to the natural Descemet membrane.
gel-MOD 95 gel-Mod 63 gel-MOD-AEMA gel-NB 63 PDLLA Descemet membrane
Papp [cm s
−1] 2.36E−02 3.06E−02 9.35E−03 2.55E−02 1.52E−02 1.20E−05[29]
sd 1.90E−02 1.51E−02 8.85E−03 2.47E−02 6.19E−03
Thickness [nm] 8.58E+02 8.68E+02 7.60E+02 9.08E+02 5.85E+02 1.00E+04[30]
sd 1.82E+02 2.62E+02 3.19E+02 5.69E+02 1.56E+02
D [cm² s−1] 2.03E−06 1.91E−06 7.10E−07 2.99E−06 8.87E−07 1.20E−08
sd 1.75E−06 1.12E−06 6.72E−07 2.18E−06 3.62E−07
cells (CEnCs) was preserved. During these experiments, no form
of additional coating agent was applied to enable the endothelial
cells to adhere to any of the membranes. Corneal endothelial cells
are known for their difficulty to expand in vitro with regard to at-
tachment and expansion, which emphasizes the propensity of the
modified gelatin derivatives to mimic the extracellular matrix. Al-
ternative approaches to enhance the attachment of cells to tissue
culture plastic include the supplementation of ROCK inhibitor
in the growth medium and through means of forced attachment
with hyaluronic acid.[56,57]
3.5.2. Phenotyping
To date, there is no consensus on the correct markers to demon-
strate the phenotypic profile of properly cultured corneal en-
dothelial cells. However, the combination of ZO-1 and Na+/K+
ATPase ion pumps are the most investigated combination of
markers reported in literature, to represent the in vivo barrier and
pump function of the cell layer, respectively.[58]
In that regard, it is shown that ZO-1 is expressed along the
lateral cell membranes of corneal endothelial cells cultured for
1 week on any of the gelatin-polyester combination membranes.
Additionally, the staining pattern clearly delineates the hexagonal
shape of the cells which is an arbitrary parameter for “healthy”
corneal endothelial cells[59] (Figure 7). Furthermore, Na+/K+ AT-
Pase are also expressed at the basolateral membranes of the
corneal endothelial cells, proving that they still express a high
density of ion pumps which is typical for CEnCs. They do not
attach well on FNC coated glass cover slips. However, they were
included to compare the control condition at the same magnifi-
cation and resolution, which would not be possible with standard
tissue culture plastic as it is too thick for fluorescence microscopy.
It can be observed that the samples with higher crosslink den-
sity display a more specific membranous staining pattern than
their less crosslinked counterparts. As mentioned before, the
Young’s modulus of gel-MOD-AEMA approaches that of the De-
scemet membrane to the greatest extent, which could explain
why the phenotype of cells grown on that membrane appears su-
perior to that of less crosslinked membranes.[33]
3.5.3. Adhesion Assay
To quantify the propensity of cells to initiate adhesion to the can-
didate scaffold materials, the surface area of focal adhesions per
cell was quantified and divided by the surface area of the cell, 24 h
after seeding. There was no significant difference in this ratio be-
tween the positive control, that is, cell culture plastic coated with
the FNC coating mix, the most favorable in vitro growth condi-
tion, and the gelatin derivatives in terms of FA/cell surface area
ratio. However, when looking to these parameters separately, the
cells cultured on plastic displayed both a bigger size of focal ad-
hesions and cell area (Figure 8B,C). Previous studies have shown
that cell size and the rate of enlargement is higher with increased
substrate stiffness.[60,61] This phenomenon can explain the larger
size of cells grown on TCP, which has a Young’s modulus around
100 000 kPa. However, a similar FA area to cell size ratio on both
plastic and gelatins indicates that within the first 24 h, the cells
are equally able to develop focal adhesions upon being seeded on
tissue culture plastic and on the gelatin derivatives.
3.5.4. Proliferation Assay
From exponential growth curves, PDT were calculated to com-
pare the growth rate on the different scaffolds (Figure 9). From
that analysis, there was no significant different between the cells
grown on gelatin scaffolds (range: 44–58 h) or the positive con-
trol (35.84± 0.97 h), that is, tissue culture plastic coated with FNC
coating mix. However, the corneal endothelial cells that grew on
coated glass cover slips had a significantly higher PDT compared
to coated tissue culture plastic, as the high stiffness of glass cre-
ates an inhospitable environment for cell homeostasis. To con-
clude, every type of gelatin scaffold is able to sustain cell growth to
the same degree as the coated culture plastic benchmark, thereby
proving its cytocompatible features in vitro.
3.5.5. Primary Corneal Endothelial Cell Culture
Primary corneal endothelial cells were cultivated on gel-MOD-
AEMA as a proof-of-concept for these membranes as an en-
dothelial scaffold. Cells were grown for 1 week on these scaffolds
without an additional FNC coating and stained for their Na+/K+
ATPase ion pumps and ZO-1 expression (Figure 10). Both
proteins were expressed at the basolateral membrane and the
cells displayed a hexagonal morphology, proving the suitability
of the developed membranes toward primary corneal endothelial
cells.
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Figure 7. Morphology and phenotype of cells grown on gelatin derivatives. Left column lists phase contrast images taken at 10× magnification. Middle
and right column are fluorescent images of cells grown on gelatin derivatives and were stained for Na+/K+ ATPase and ZO-1 respectively. Note that the
gel-NB DS63 was taken on a 40× magnification whereas the other images were recorded at 20× magnification.
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Figure 8. Graphical representation of A) the ratio of the focal adhesion area of a cell divided by the cell surface area, B) the focal adhesion area per cell,
and C) the cell surface area.
Figure 9. Population doubling times of CEnC grown on modified gelatin.
There was no significant different between the positive control (plastic
FNC) and the crosslinked gelatins. CenC did grown slower on a glass cov-
erslip coated with FNC.
4. Conclusion
This study demonstrates the potential of applying PDLLA-gelatin
multilayer membranes for corneal endothelial tissue engineer-
ing. This strategy resulted in ultrathin membranes (i.e., <1 µm)
that benefit both from a comparable mechanical strength as the
natural membranes (±5 MPa) due to the presence of the PDLLA
and the ECM mimicking capacity of the gelatin derivatives. These
materials prove very suitable for the application as every gelatin
derivative will be hydrolyzed and broken down into peptides in
vivo, similarly to collagen breakdown in the human body. The
PDLLA supporting polymer, will be degraded to lactic acid, which
should not pose any problems in the corneal environment as
85% of glucose in the cornea is metabolized into lactate which is
even considered as a contributing anion flux to maintain corneal
transparency. Although, the gelatin coatings have proven to be a
very suitable ECM mimic in the present application, the experi-
ments do not further reveal an outperforming candidate among
the different modified gelatins both in terms of physico-chemical
and biological performance. However, the samples with the high-
est Young’s modulus, namely gel-MOD DS 95, and gel-MOD-
AEMA, are considered to be a better mimic of the Descemet
membrane, due to a closer match to the native membrane in
terms of mechanical properties. Therefore, for future studies,
the choice for a suitable gelatin derivative can be made based
on most straightforward membrane fabrication. As a result, the
most promising candidate gelatin derivative would be gel-MOD-
AEMA due to the following reasons. First, gel-MOD-AEMA dis-
plays a higher Young’s modulus which is a closer match to the in
vivo value of the Descemet membrane. Second, due to its higher
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Figure 10. Primary corneal endothelial cells cultivated on gel-MOD-AEMA and stained for their respective A) ZO-1 and B) Na+/K+ ATPase ion pumps
(40× magnification).
degree of crosslinking, it is expected to swell less in vivo and de-
grade at a slower rate which is beneficial as corneal endothelial
cells secrete only very limited extracellular matrix through life,
making a slowly degrading ECM mimicking material more in-
teresting. Third, gel-MOD-AEMA can easily be processed at room
temperature in contrast to the other assessed gelatin derivatives.
Furthermore, in contrast to the step-growth based norbornene
derivatives, processing of a chain growth derivative (i.e., gel-MOD
and gel-MOD-AEMA) can occur in a straightforward manner
since there are no issues related to thiol stability at the required
elevated temperatures to keep gelatin in solution or preliminary
crosslinking due to the high reactivity. As a proof-of-concept ex-
periment, the gel-MOD-AEMA membranes were also used to cul-
ture primary corneal endothelial cells, which exhibited the de-
sirable hexagonal morphology, Na+/K+ ATPase ion pumps and
ZO-1 protein expression. Through this innovative combination
of PDLLA with gelatin, we have managed to incorporate the me-
chanical strength of the polyester and the ECM-mimicking ca-
pacity of gelatin in an ultra-thin scaffold for corneal endothelial
transplantation.
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